COMPLY or DIE: Vaxx-Partheid in the Operating Room | WHAT REALLY HAPPENED X-Frame-Options: SAMEORIGIN

COMPLY or DIE: Vaxx-Partheid in the Operating Room

For nearly 20 years, I’ve reported on America’s medical welcome mat for chronically sick illegal aliens. Under a 1986 federal law, “unauthorized immigrants” with conditions such as kidney disease and cancer cannot be denied emergency room care, regardless of their immigration status or inability to pay. Open-borders politicians insist health care is a “right” that every last border-jumper is entitled to—and which every last American taxpayer must subsidize.

According to estimates from 2019 cited in a recent study published by the American Journal of Kidney Disease, there are between nearly 9,000 illegals with kidney failure in the U.S. There’s now a COVID-era push to provide them not only with emergency-room dialysis (at an estimated cost of $400,000-per-illegal alien-per-year), but also outpatient dialysis under Medicaid. Conveniently, the United Network for Organ Sharing and Organ Procurement and Transplantation Network do not document immigration status, so there are no reliable estimates of exactly how many illegal aliens have received organ transplants in the U.S. At least one scientific journal article identified 400 illegal aliens who had received kidney transplants since 2005 —most in California at taxpayer expense.

Keep all this government-backed generosity for illegal alien patients in mind as I tell you about the plight of Leilani Lutali, a law-abiding American citizen and Colorado Springs executive recruiter diagnosed with Stage IV kidney disease last November. Her condition worsened over the summer, leading her medical providers at UCHealth in Denver to begin discussion of an organ transplant. Blessed with a close-knit network of friends through her local Bible study, Leilani found a living donor in Jaimee Fougner, a former Air Force medic, triathlete, and medical assistant who has spent more than two decades in the health care field.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA